MARLBOROUGH, Mass.-Thursday 6 January 2022 [ AETOS Wire ]
(BUSINESS WIRE)-- Hologic, Inc. (NASDAQ: HOLX) announces the addition of the Aptima® SARS-CoV-2 assay to its Global Access Initiative (GAI), a program designed to expand access to critical diagnostic testing in resource-limited countries.